Based in Dallas, Texas, North Dallas Research Associates (NDRA) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry.
NDRA was founded in 2003 by Dr. M. Akram Khan. Although our primary research focus is Cardiology, we have experience in manytherapeutic areas including:
- Hypertension
- Hyperlipedemia
- A-FIB
- Acute Coronary Syndrome
- Phase 4 Device Studies
- Diabetic Studies
- Coronary Artery Disease
- PAD
- CHF
- Stroke
- Pacemaker
- ICDs
- Coronary & Peripheral Stents
- Obesity
- OTC
- Hyperlipidemia Metabollic Syndrome
- Chronic Angina
- Carotid & Peripheral Vascular Diseases
- AAA
- Vericose Vein
North Dallas Research Associates is experienced in:
- Pharmacokinetic/Pharmacodynamic
- Dose Ranging Studies
- Drug-Drug Interaction Studies
- Safety & Efficacy
- Proof of Concept Studies
- Inpatient/Outpatient Studies
NDRA has partnered with the following pharmaceutical sponsors:
- Bayer Pharmaceuticals
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- Hoffman-LaRoche, Inc.
- Biotronik
- Cordis
- Novartis Pharmaceutical Corporation
- Pfizer, Inc.
- Roche Global Development
- Sanofi Aventis
- Schering-Plough Corporation
- Wyeth-Ayerst
Go to the North Dallas Research Associates website for more information on our clinical research trials.
